Ongoing clinical trials of nonviral siRNA therapeutics
Short interfering RNAs (siRNA) are a powerful class of genetic medicines whose clinical
translation can be hindered by their suboptimal delivery properties in vivo. Here, we provide …
translation can be hindered by their suboptimal delivery properties in vivo. Here, we provide …
Clinical delivery of circular RNA: lessons learned from RNA drug development
Circular RNAs (circRNA) represent a distinct class of covalently closed-loop RNA molecules,
which play diverse roles in regulating biological processes and disease states. The …
which play diverse roles in regulating biological processes and disease states. The …
Advances in mRNA therapeutics for cancer immunotherapy: from modification to delivery
RNA vaccines have demonstrated their ability to solve the issues posed by the COVID-19
pandemic. This success has led to the renaissance of research into mRNA and their …
pandemic. This success has led to the renaissance of research into mRNA and their …
Tumor-targeted exosomes for delivery of anticancer drugs
Exosomes are small phospholipid bilayer vesicles that are naturally produced by all living
cells, both prokaryotes and eukaryotes. The exosomes due to their unique size, reduced …
cells, both prokaryotes and eukaryotes. The exosomes due to their unique size, reduced …
Engineered nanomaterials that exploit blood-brain barrier dysfunction for delivery to the brain
The blood–brain barrier (BBB) is a highly regulated physical and functional boundary that
tightly controls the transport of materials between the blood and the brain. There is an …
tightly controls the transport of materials between the blood and the brain. There is an …
Exosome for mRNA delivery: strategies and therapeutic applications
Messenger RNA (mRNA) has emerged as a promising therapeutic molecule with numerous
clinical applications in treating central nervous system disorders, tumors, COVID-19, and …
clinical applications in treating central nervous system disorders, tumors, COVID-19, and …
Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives
Abstract Exosomes are nanosized (size~ 30–150 nm) natural vesicular structures released
from cells by physiological processes or pathological circumstances. Exosomes are growing …
from cells by physiological processes or pathological circumstances. Exosomes are growing …
Exosome-based carrier for RNA delivery: progress and challenges
Y Lu, W Huang, M Li, A Zheng - Pharmaceutics, 2023 - mdpi.com
In the last few decades, RNA-based drugs have emerged as a promising candidate to
specifically target and modulate disease-relevant genes to cure genetic defects. The key to …
specifically target and modulate disease-relevant genes to cure genetic defects. The key to …
Circular RNA vaccine in disease prevention and treatment
D Niu, Y Wu, J Lian - Signal transduction and targeted therapy, 2023 - nature.com
CircRNAs are a class of single-stranded RNAs with covalently linked head-to-tail topology.
In the decades since its initial discovery, their biogenesis, regulation, and function have …
In the decades since its initial discovery, their biogenesis, regulation, and function have …
Engineered exosome for drug delivery: recent development and clinical applications
J Tian, Z Han, D Song, Y Peng, M Xiong… - International Journal …, 2023 - Taylor & Francis
Exosomes are nano-sized membrane vesicles that transfer bioactive molecules between
cells and modulate various biological processes under physiological and pathological …
cells and modulate various biological processes under physiological and pathological …